Alerlisin en es it fr

Alerlisin Brand names, Alerlisin Analogs

Alerlisin Brand Names Mixture

  • No information avaliable

Alerlisin Chemical_Formula


Alerlisin RX_link

Alerlisin fda sheet

Alerlisin FDA

Alerlisin msds (material safety sheet)

Alerlisin Synthesis Reference

E. Baltes et al., U.S. Pat. 4,525,358 (1985)

Alerlisin Molecular Weight

388.888 g/mol

Alerlisin Melting Point


Alerlisin H2O Solubility

101 mg/L

Alerlisin State


Alerlisin LogP


Alerlisin Dosage Forms


Alerlisin Indication

For the relief of symptoms associated with seasonal allergic rhinitis, perennial allergic rhinitis and the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria

Alerlisin Pharmacology

Cetirizine, the active metabolite of the piperazine H1-receptor antagonist hydroxyzine, is used to treat chronic idiopathic urticaria, perennial allergic rhinitis, seasonal allergic rhinitis, allergic asthma, physical urticaria, and atopic dermatitis.

Alerlisin Absorption

mean peak plasma concentration (Cmax) of 114 ng/mL at a time (Tmax) of 2.2 hours postdose was observed for cetirizine

Alerlisin side effects and Toxicity

Somnolence (sleepiness or unusual drowsiness), restlessness, irritability

Alerlisin Patient Information

Alerlisin Organisms Affected

Humans and other mammals